Ara
Toplam kayıt 5, listelenen: 1-5
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
(BMC, 04.05.2021)
Background and objectives
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose ...
Visual and Quantitative Assessment of COVID-19 Pneumonia on Chest CT: The Relationship with Disease Severity and Clinical Findings
(BENTHAM SCIENCE PUBL LTD, 2021)
Background: Lungs are the primary organ involved in COVID-19, and the severity of pneumonia in COVID-19 patients is an important cause of morbidity and mortality.
Aim: We aimed to evaluate the pneumonia severity through ...
Neurological symptoms and findings in COVID-19: a prospective clinical study
(Taylor & Francis Group, 16.07.2021)
Objective: We sought to evaluate neurologic symptoms and findings in patients with COVID-
19 infection hospitalized in a ward and intensive care unit (ICU).
Methods: This study was designed as a prospective study. ...
INVESTIGATION OF THE IMMUNOMODULATOR EFFECT OF BETA GLUCAN IN THE EXPERIMENTAL INTRAABDOMINAL BACTERIEMIA MODEL WITH STAPHYLOCOCCUS AUREUS
(Afyonkarahisar Sağlık Bilimleri Üniversitesi, 2022)
OBJECTIVE: The purpose of this study is to investigate the immunomodulatory effect of beta glucan in an experimental model of intraabdominal bacteremia induced by S. aureus.
MATERIAL AND METHODS: Thirty Wistar albino rats ...
Evaluation of secondary infections in COVID-19 patients hospitalized in intensive care unit: Retrospective observational study
(Türkiye Klinikleri Yayınevi, 2022)
bjective: Patients infected with severe acute respira- tory syndrome-coronavirus-2 may progress with severe clinical symp- toms and patients may be hospitalized in intensive care for a long time. In patients with long-term ...